Modifying the skin's immune system to improve overall immune responses
Engineering the Skin Immune System to Induce Systemic Immune Responses
This study is looking at how we can boost the immune system through the skin using a special patch with tiny needles, and it's especially for older adults who might need a little extra help with their immune responses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11015901 on NIH RePORTER |
What this research studies
This research focuses on the skin as a vital immune organ and aims to enhance its ability to trigger systemic immune responses. By using a novel dissolvable microneedle array, the study will deliver immune modulators directly to the skin, which may help improve immune function, especially in older adults who often have weakened immune responses. The research will involve both laboratory studies and translational studies using living human skin to ensure that findings can quickly advance to clinical applications. The goal is to better understand how to manipulate skin immunity to benefit overall health.
Who could benefit from this research
Good fit: Ideal candidates for this research include older adults who may have weakened immune systems and are at higher risk for diseases.
Not a fit: Patients with intact immune systems or those who are not elderly may not receive significant benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccine responses and better disease resistance, particularly for older adults.
How similar studies have performed: Other research has shown promise in using skin-based immunomodulation techniques, suggesting potential for success in this novel approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Falo, Louis D — University of Pittsburgh at Pittsburgh
- Study coordinator: Falo, Louis D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.